Navigation Links
Generra Focus 5

ProductsGenerra Focus 5
Company Generra Medical
Item Generra Focus 5
Features 
  • ECG - NIBP - SpO2 - Temperature
  • Large LCD color display
  • 4 to 8 channels
  • Color selectable
  • Simple to use international menu
  • Programmable NIBP cycles
  • Programmable audible/visual alarms
  • 5 minutes real time waveform history on screen review
  • 24 hours trends information on all parameters
  • Simultaneous display of all parameters
  • Appropriate for adult, pediatric & neonate patients
  • AC/DC operation
  • Warranty: 1 year parts & labor
    • Description Generra Focus 5 is a basic vital sign monitor.

    Adult, pediatric, and neonatal.

    Providing high quality, affordable products for efficiency in patient care.
    Info Generra Medical
    Customer Service: (727) 441-3444
    Web site: http://www.generramedical.com/

    Related medicine products :

    1. Generra Narkotron II
    2. Focus Lens Drops
    3. Focus Dailies Toric
    4. Focus Toric Monthly lenses
    5. Focus Progressives
    6. Focus Dailies Progressives
    7. Focus Dailies
    8. Focus 1-2 Week Lenses
    9. Focus Monthly Lenses
    10. Focus Night & Day
    11. Focus
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products:
    (Date:12/6/2009)... in Cambridge have discovered that the loss of a key ... is the first study to show that this kind of ... in Nature . , The study, led by Dr ... Hurles from the Wellcome Trust Sanger Institute, looked at 300 ... entire genome looking for types of mutation known as copy ...
    (Date:12/6/2009)... College of Wisconsin, in Milwaukee, found a substantial variation ... disease complications in children. Barriers to its use on ... identified. The study led by Amanda M. Brandow, ... College and Children,s Research Institute at the Children,s Hospital ... of Hematology meeting Dec. 7, 2009, in New Orleans. ...
    (Date:12/6/2009)... clotting, or coagulation, is an important process that ... injured. Sometimes, however, clots form on the inside ... not dissolve naturally, a potentially life-threatening situation requiring ... Meeting of the American Society of Hematology reveals ... and heparin with the hope of preventing clots ...
    (Date:12/6/2009)... with the Greater VA Healthcare System in West Los Angeles, will ... to soar to more than 5,000 veterans, active military personnel and ... ... 2009 -- Volunteer organizations and members of the community, in cooperation ... once again create a holiday party. This year,s attendance is expected ...
    (Date:12/5/2009)... There have been significant scientific advances in the ... gain a better understanding of how certain diseases progress ... patients with the best care. Research presented today at ... Hematology explores optimal induction therapies for managing multiple myeloma, ...
    Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
    ... LONG ISLAND, N.Y., Oct. 2 Suzanne Somers, ... some of Long Island,s most,brilliant, wellness oriented doctors ... 4th NAVEL Expo (Nutrition, Aesthetics, Vitality,Efficacy, Life ... ... the,fundamentals of weight loss, beauty, fitness, longevity, vitality ...
    ... recommendations that restrict women who have previously been pregnant ... impact on the blood supply. The reason is a ... Injury, or TRALI. According to the FDA, TRALI is ... and female patients. Pall Corporation (NYSE: PLL), a leading ...
    ... Fight Against Women,s ... Cancers, ... introduced in the U.S. House of,Representatives on Thursday, Sept. 27 and the ... legislation, is issuing a "call to action" for ovarian cancer,survivors, their families, ...
    ... System Up-Time and Improved Overall ... ... Diagnostics (http://www.siemens.com/diagnostics ) announced today,worldwide availability of version 2.0 ... software will be a required upgrade for,all existing customers and ...
    ... a Raleigh,dentist, will bicycle from Murphy to Manteo, N.C., Oct. ... the 6-day 750-mile solo ride, called "The Ride for Oral ... to call attention to the importance of annual oral cancer,exam," ... major European cycling events,was inspired to undertake the trek by ...
    ... MONTREAL, Oct. 2 /PRNewswire-FirstCall/ - Haemacure Corporation,(TSX:HAE), a ... Mr. Joseph Galli, Chairman and Chief Executive,Officer, will ... will be,speaking on Wednesday, October 3, 2007 at ... City. About BioContact Quebec 2007 BioContact ...
    Other Medicine News:Health News:Healthy Weight Loss Begins With What You Permit to Enter Your Mind, More So Than Even Your Mouth! 2Health News:New transfusion rules restrict donations from previously pregnant women 2Health News:New transfusion rules restrict donations from previously pregnant women 3Health News:New Ovarian Cancer Biomarker Research Act Introduced 2Health News:New Ovarian Cancer Biomarker Research Act Introduced 3Health News:Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software 2Health News:Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software 3Health News:Raleigh Dentist to Bicycle Across North Carolina to Raise Oral Cancer Awareness 2Health News:Presentation at Bio Contact Quebec 2007 2
    (Date:12/4/2009)... Hospira, Inc. (NYSE: HSP ), a ... announced the launch of its next-generation 50 mL and ... solutions, and now offers a complete size range (50 ... VisIV product. The launch of the 50 mL and ...
    (Date:12/4/2009)... HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced the ... by PennWell Corporation , a leader in ... dentistry. The course focuses on patient views ...
    (Date:12/4/2009)... WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: ... Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine ... antidepressants in adults with Major Depressive Disorder (MDD). SEROQUEL ... by the FDA to treat both major depressive disorder ...
    Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Award Winning Disability Lifestyle Magazine Celebrates 20 Years of Publication And 20 Years of Employing People with Disabilities 5653 1Award Winning Disability Lifestyle Magazine Celebrates 20 Years of Publication And 20 Years of Employing People with Disabilities 5653 2CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 1CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 2CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 3CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 4Internet fuels virtual subculture for sex trade study finds 59921 1Internet fuels virtual subculture for sex trade study finds 59921 2